While it’s been evident for years that prevention and detection alone are not enough for effective cybersecurity, the arrival ...

The cybersecurity leaders are leaning into identity security, a critical cyber segment, as AI agents outnumber humans ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Everyone is racing to point powerful AI models at drug discovery. A growing camp argues the real prize is the layer beneath the models — the connected biological knowledge they reason over — and that ...

Alex L. Zhang was 13 years old when he published a video game that went viral. More than 100,000 people bought the game for ...

Building a model capable of RSI would require automating a range of specialist tasks currently carried out by humans. At present data scientists work on the theory of AI and coders put it into ...

Credit: VentureBeat made with OpenAI ChatGPT-Images-2.0 Anthropic co-founder and CEO Dario Amodei said it was coming, but it still feels like a milestone: More than 80% of the code merged into ...

Educational P-Code Virtual Machine and Debugger plugin for IntelliJ IDEA. P-Code VM helps students learn compiler construction, intermediate code generation, stack machines, recursion, frames, and ...

Thanks for attending the 2026 Bank of America Healthcare Conference. My name is Alec Stranahan. I cover Recursion and SMid Biotech at Bank of America. And I'm pleased to be joined today by Ben Taylor, ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

SALT LAKE CITY, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and ...